暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
PRVA240517P20000
- 2.24
- 0.000.00%
延時15分鐘行情交易中 04/29 13:44 (美東)
0.00最高價0.00最低價
0.00今開2.24昨收0張成交量0張未平倉合約數20.00行權價0.00成交額0.00%引伸波幅8.89%溢價2024/05/17到期日3.69内在价值100合約乘數-5天距到期日0.00時間價值100合約規模美式期權類型--Delta--Gamma7.28槓桿倍數--Theta--Rho--有效槓桿--Vega
分時
- 5日
- 日K
新聞
巴克萊將Privia的健康維持在同等體重
巴克萊將Privia的健康維持在同等體重
快訊 | Privia Health Group Inc.：巴克萊將目標價格從22美元下調至19美元
Privia Health Group（PRVA）獲巴克萊銀行 "持有 "評級
信託證券維持Privia Health的買入水平
信託證券維持Privia Health的買入水平
12位分析師評級對Privia Health Gr有何看法
在過去三個月中，12位分析師提供了Privia Health Gr（納斯達克股票代碼：PRVA）的評級，顯示了看漲和看跌的觀點。總結了他們最近的評估，表b
快訊 | Privia Health Group Inc：信託證券將目標價格從28美元下調至24美元
評論
Jefferies analysts predict a shift to value-based care as a defining trend in healthcare. They foresee Astrana Health's unique model gaining attention, closing the valuation gap with popular peers. Privia is also praised for its balanced, sustainable earnings growth.
Jefferies Cautious on Value Based Care Providers; Favors ASTH, PRVA, TOIPrivia Health's CEO, Parth Mehrotra, welcomes Edward C. Fargis, citing his vast experience in corporate governance, compliance and strategic transactions. Fargis is eager to contribute to a profitable growth strategy benefiting stakeholders.
$Privia Health(PRVA.US$2021年上市，營收近兩年高速增長，營業利潤從虧損2.2億縮小到虧損0.19億，淨利潤受所得稅返還影響虧損略小。
2023上半年營收增長23.2%，營業利潤扭虧達到0.14億，淨利潤扭虧達到0.13億，不過上半年應收帳款從1.9億增加到3.2億，增幅達1.3億，2023年1季度商譽也增加了0.49億，增長是否依賴於併購需要更多數據。
目前市盈率TTM爲77，如果全年淨利達到0.26億，市盈率爲104，暫時觀望。
2023上半年營收增長23.2%，營業利潤扭虧達到0.14億，淨利潤扭虧達到0.13億，不過上半年應收帳款從1.9億增加到3.2億，增幅達1.3億，2023年1季度商譽也增加了0.49億，增長是否依賴於併購需要更多數據。
目前市盈率TTM爲77，如果全年淨利達到0.26億，市盈率爲104，暫時觀望。
已翻譯
1 | Below is a look at the top insider trades with the biggest value in the past week.
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...
13
2
閱讀更多